Health ❯ Clinical Research ❯ Drug Development

Clinical Trials

Efficacy Studies Pharmacokinetics Z944 (Ulixacaltamide) Semaglutide Studies Metabolic Disorders Therapeutics Antibiotic Efficacy

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

Closing is slated for Oct. 8 pending customary conditions under the company’s effective shelf registration.